Tibco Software has announced a data access, normalisation, pattern detection, treatment comparison and functional analysis solution for scientists analysing genomic expression data.
Integromics Biomarker Discovery 2.0 for Tibco Spotfire provides pharmaceutical, biotechnology and academic research groups with a genomic data analysis environment that quickly finds and categorises complex patterns.
With interactive analysis and high-impact visualisation capabilities, Integromics Biomarker Discovery 2.0 for Tibco Spotfire rapidly reveals insights and unexpected relationships in genomics data.
This allows researchers and scientists to examine the expression and annotation dimensions of their data and perform a variety of numerical analyses in a single application.
Pharmaceutical companies can also use Tibco Spotfire as a flexible analytics platform to combine and analyse new types of data to more quickly pursue hypotheses and research strategies.
